Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.

STAR protocols
Authors
Keywords
Abstract

Recognition of Cas9 and other proteins encoded in delivery vectors has limited CRISPR technology in vivo. Here, we present a protocol for genome engineering using selective CRISPR antigen removal (SCAR) lentiviral vectors in Renca mouse model. This protocol describes how to conduct an in vivo genetic screen with a sgRNA library and SCAR vectors that can be applied to different cell lines and contexts. For complete details on the use and execution of this protocol, please refer to Dubrot et al. (2021)..

Year of Publication
2023
Journal
STAR protocols
Volume
4
Issue
1
Pages
102082
Date Published
02/2023
ISSN
2666-1667
DOI
10.1016/j.xpro.2023.102082
PubMed ID
36861834
Links